Martina Callaghan

Last updated
Martina F. Callaghan
Alma mater University of Limerick
Imperial College London
Scientific career
Institutions Wellcome Centre for Human Neuroimaging
Thesis Padé methods for image reconstruction and feature extraction in MRI  (2005)

Martina F. Callaghan is an Irish medical physicist who is the Director of the Wellcome Centre for Human Neuroimaging at the UCL Queen Square Institute of Neurology. Her research considers the development of in-vivo histology using MRI.

Contents

Early life and education

Callaghan studied physics at the University of Limerick. She moved to Imperial College London for her graduate research, where she joined Joseph Hajnal and David Larkman at Hammersmith Hospital and earned her Ph.D. [1] [2] Her research considered image reconstruction using under-sampled datasets. [3] [4] She worked as a postdoctoral researcher at Imperial College London and Middlesex University, focusing on parallel transmit technology, lipid quantification in clinical populations and the use of nanotechnology in oncology. [2]

Research and career

Callaghan joined the Wellcome Centre for Human Neuroimaging in 2012. She was promoted to Deputy Head of Physics in 2013, and became Deputy Head of the Physics Group in 2013. In 2016 she was appointed Head of Physics. In 2019 she became Deputy Centre Director and in 2020 was promoted to Professor of MRI Physics. [2]

Callaghan was responsible for the launch of 7T MRI at University College London. [5] Her research considers advanced, microstructure brain imaging as a means to understand the structure and function of brains. [2] She makes use of quantitative imaging to understand tissue microstructure through measurements of iron levels and myelination. In particular, 7T MRI offers hope to interrogate the neural circuitry that is involved with human cognition. [6] She is interested in inter-individual ageing [7] and in-vivo histology using MRI. [1]

In 2022, Callaghan was appointed Director of the Wellcome Centre for Human Neuroimaging. [6]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Magnetic resonance imaging</span> Medical imaging technique

Magnetic resonance imaging (MRI) is a medical imaging technique used in radiology to form pictures of the anatomy and the physiological processes of the body. MRI scanners use strong magnetic fields, magnetic field gradients, and radio waves to generate images of the organs in the body. MRI does not involve X-rays or the use of ionizing radiation, which distinguishes it from CT and PET scans. MRI is a medical application of nuclear magnetic resonance (NMR) which can also be used for imaging in other NMR applications, such as NMR spectroscopy.

Blood-oxygen-level-dependent imaging, or BOLD-contrast imaging, is a method used in functional magnetic resonance imaging (fMRI) to observe different areas of the brain or other organs, which are found to be active at any given time.

<span class="mw-page-title-main">Neuroimaging</span> Set of techniques to measure and visualize aspects of the nervous system

Neuroimaging is the use of quantitative (computational) techniques to study the structure and function of the central nervous system, developed as an objective way of scientifically studying the healthy human brain in a non-invasive manner. Increasingly it is also being used for quantitative studies of brain disease and psychiatric illness. Neuroimaging is a highly multidisciplinary research field and is not a medical specialty.

<span class="mw-page-title-main">Wellcome Centre for Human Neuroimaging</span> Laboratory of the University College London

The Wellcome Centre for Human Neuroimaging at University College London is a world-leading interdisciplinary centre for neuroimaging research based in London, United Kingdom. Researchers at the Centre use expertise to investigate how the human brain generates behaviour, thoughts and feelings and how to use this knowledge to help patients with neurological and psychiatric disorders. Human neuroimaging allows scientists to non-invasively investigate the brain structure and functions including Action, Decision Making, Emotion, Hearing, Language, Memory, Navigation, Seeing, Self awareness, Social Behaviour and the Bayesian Brain

Burton Drayer, MD, FACR, FANN, is an American radiologist and nationally recognized authority on the use of computed tomography and magnetic resonance imaging for diagnosing neurological disorders. From 2003 to 2008, he served as president, The Mount Sinai Hospital. As of 2020, he is the Charles M. and Marilyn Newman Professor and System Chair, Radiology, for The Mount Sinai Health System and Icahn School of Medicine at Mount Sinai Hospital in New York City.

Robert Turner is a British neuroscientist, physicist, and social anthropologist. He has been a director and professor at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany, and is an internationally recognized expert in brain physics and magnetic resonance imaging (MRI). Coils inside every MRI scanner owe their shape to his ideas.

<span class="mw-page-title-main">Quantitative susceptibility mapping</span>

Quantitative Susceptibility Mapping (QSM) provides a novel contrast mechanism in Magnetic Resonance Imaging (MRI) different from traditional Susceptibility Weighted Imaging. The voxel intensity in QSM is linearly proportional to the underlying tissue apparent magnetic susceptibility, which is useful for chemical identification and quantification of specific biomarkers including iron, calcium, gadolinium, and super paramagnetic iron oxide (SPIO) nano-particles. QSM utilizes phase images, solves the magnetic field to susceptibility source inverse problem, and generates a three-dimensional susceptibility distribution. Due to its quantitative nature and sensitivity to certain kinds of material, potential QSM applications include standardized quantitative stratification of cerebral microbleeds and neurodegenerative disease, accurate gadolinium quantification in contrast enhanced MRI, and direct monitoring of targeted theranostic drug biodistribution in nanomedicine.

<span class="mw-page-title-main">PET-MRI</span>

Positron emission tomography–magnetic resonance imaging (PET–MRI) is a hybrid imaging technology that incorporates magnetic resonance imaging (MRI) soft tissue morphological imaging and positron emission tomography (PET) functional imaging.

<span class="mw-page-title-main">Magnetic resonance imaging of the brain</span>

Magnetic resonance imaging of the brain uses magnetic resonance imaging (MRI) to produce high quality two-dimensional or three-dimensional images of the brain and brainstem as well as the cerebellum without the use of ionizing radiation (X-rays) or radioactive tracers.

Mark Steven Cohen is an American neuroscientist and early pioneer of functional brain imaging using magnetic resonance imaging. He currently is a Professor of Psychiatry, Neurology, Radiology, Psychology, Biomedical Physics and Biomedical Engineering at the Semel Institute for Neuroscience and Human Behavior and the Staglin Center for Cognitive Neuroscience. He is also a performing musician.

<span class="mw-page-title-main">Philip Batchelor</span>

Philip Batchelor, was a Swiss-British academic in the fields of mathematics and medical imaging.

Arno Villringer is a Director at the Department of Neurology at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany; Director of the Department of Cognitive Neurology at University of Leipzig Medical Center; and Academic Director of the Berlin School of Mind and Brain and the Mind&Brain Institute, Berlin. He holds a full professorship at University of Leipzig and an honorary professorship at Charité, Humboldt-Universität zu Berlin. From July 2022 to June 2025 he is the Chairperson of the Human Sciences Section of the Max Planck Society.

<span class="mw-page-title-main">Eleanor Maguire</span> Irish neuropsychologist

Eleanor Anne Maguire is an Irish neuroscientist. Since 2007, she has been Professor of Cognitive Neuroscience at University College London where she is also a Wellcome Trust Principal Research Fellow.

Functional magnetic resonance spectroscopy of the brain (fMRS) uses magnetic resonance imaging (MRI) to study brain metabolism during brain activation. The data generated by fMRS usually shows spectra of resonances, instead of a brain image, as with MRI. The area under peaks in the spectrum represents relative concentrations of metabolites.

The following outline is provided as an overview of and topical guide to brain mapping:

The history of magnetic resonance imaging (MRI) includes the work of many researchers who contributed to the discovery of nuclear magnetic resonance (NMR) and described the underlying physics of magnetic resonance imaging, starting early in the twentieth century. MR imaging was invented by Paul C. Lauterbur who developed a mechanism to encode spatial information into an NMR signal using magnetic field gradients in September 1971; he published the theory behind it in March 1973. The factors leading to image contrast had been described nearly 20 years earlier by physician and scientist Erik Odeblad and Gunnar Lindström. Among many other researchers in the late 1970s and 1980s, Peter Mansfield further refined the techniques used in MR image acquisition and processing, and in 2003 he and Lauterbur were awarded the Nobel Prize in Physiology or Medicine for their contributions to the development of MRI. The first clinical MRI scanners were installed in the early 1980s and significant development of the technology followed in the decades since, leading to its widespread use in medicine today.

<span class="mw-page-title-main">MRI sequence</span>

An MRI sequence in magnetic resonance imaging (MRI) is a particular setting of pulse sequences and pulsed field gradients, resulting in a particular image appearance.

Charlotte Stagg is a British neurophysiologist who is a professor at the University of Oxford. She leads the Physiological Neuroimaging Group.

<span class="mw-page-title-main">Richard Frackowiak</span> Neuroimaging researcher (born 1950)

Richard Stanislaus Joseph Frackowiak, born 26 March 1950 in London, is a British and French neurologist and neuroscientist. He is best known for his role in the development of neuroimaging, as the founding director of the Functional Imaging Laboratory (FIL) at University College London (UCL) and as one of the initiators, in 2013, of the Human Brain Project (HBP), a ten-year European project coordinated by the École Polytechnique Fédérale de Lausanne (EPFL) with the goal of advancing knowledge in the fields of neuroscience, computing and brain-related medicine.

References

  1. 1 2 UCL (2021-09-07). "Queen Square Inaugural Lectures: Professors Martina Callaghan and Vincenzo Libri". UCL Queen Square Institute of Neurology. Retrieved 2022-04-10.
  2. 1 2 3 4 "Prof Martina Callaghan". UCL IRIS - Institutional Research Information Service. Retrieved 2022-04-10.
  3. Callaghan, Martina (2005). Padé methods for image reconstruction and feature extraction in MRI (Thesis). OCLC   930640531.
  4. Callaghan, Martina F.; Larkman, David J.; Hajnal, Joseph V. (2005). "Padé methods for reconstruction and feature extraction in magnetic resonance imaging". Magnetic Resonance in Medicine. 54 (6): 1490–1502. doi: 10.1002/mrm.20720 . ISSN   0740-3194. PMID   16254953. S2CID   10752430.
  5. "FIL Physics". sites.google.com. Retrieved 2022-04-10.
  6. 1 2 UCL (2022-04-07). "Professor Martina Callaghan is appointed as the Head of the Department of Imaging Neuroscience". UCL Queen Square Institute of Neurology. Retrieved 2022-04-10.
  7. Callaghan, Martina F.; Freund, Patrick; Draganski, Bogdan; Anderson, Elaine; Cappelletti, Marinella; Chowdhury, Rumana; Diedrichsen, Joern; FitzGerald, Thomas H.B.; Smittenaar, Peter; Helms, Gunther; Lutti, Antoine (2014). "Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging". Neurobiology of Aging. 35 (8): 1862–1872. doi:10.1016/j.neurobiolaging.2014.02.008. ISSN   0197-4580. PMC   4024196 . PMID   24656835.